Harmony Biosciences Holdings Inc. (HRMY) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Harmony Biosciences Holdings Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$38.50
+1.45% today
Market cap
$2.2B
Overall quality
—
Kronos AI 30-day
+0.5%
5 of 8 simulated paths end higher
Harmony Biosciences Holdings Inc. (HRMY) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.2B. It trades at $38.50, up 1.45% today. 8 analysts' average target of $46.00 implies +19.5% from today's price. Kronos AI's 30-day forecast is +0.5% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $46.00 |
| Low – high | $30.00 – $60.00 |
| Analysts | 8 |
| Upside to average | +19.5% |
Kronos AI 30-day forecast
| Expected close | $38.12 (+0.5%) |
| Likely range | −5.0% … +6.5% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.